Molecular genetic studies on selected candidate genes revealed frequent NF2 gene mutations in intramedullary spinal ependymomas, while deletions of the CDKN2A gene were frequent in intracranial supratentorial ependymomas but rare in ependymomas from other locations [106] (Figure 5). The gene discussed is NF2; the disease is ependymoma.